Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Cellino logo — Awaken your best stem cells—through machines.

Cellino

Awaken your best stem cells—through machines.

Founded 2017 United States Cambridge, United States 112 employees Series A Total: $121.01M Biotechnology, Design

General Information

Company Name Cellino
Founded Year 2017
Location United States Cambridge, United States
Founders / Decision Makers
Team member
Employees 112
Industries Biotechnology, Design
Funding Stage Series A
Business Model B2B, D2C, B2D
Revenue Model Service Fee, Licensing, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with Cellino. To contact Cellino, visit cellinobio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cellino compare?

A PDF of Cellino and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cellino soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Nov 03, 2026

Co-Founder & CEO Dr. Nabiha Saklayen will speak at the Eudēmonia Summit 2026 in West Palm Beach.

Promotion Launched Nov 03, 2026

Cellino launched a promotion offering $100 off tickets to the Eudēmonia Summit using a specific code.

Product Launch Oct 15, 2026

Cellino partnered with Vinod Khosla to introduce Reservoir, a personal immune cell preservation service.

Cellino a competitor of yours? Have our desk watch it

About Cellino

Cellino, founded in 2017, is pioneering in the fields of Biotechnology and Design from its base in the United States. With a bold slogan, "Awaken your best stem cells—through machines," Cellino aims to revolutionize health by introducing a scalable biomanufacturing technology for personalized cell, tissue, and organ replacement therapies. Their mission is to increase healthspan for billions globally, spanning generations.

Recently, Cellino secured a $25.00M grant investment on 01 September 2024, funded by the US Department of Health and Human Services. This noteworthy investment underscores the company's potential and the confidence shown by esteemed investors in its innovative approach to transformative medicine. For venture capitalists, Cellino presents a compelling opportunity to invest in a visionary entity at the forefront of health innovation.

Business keywords: biomanufacturing technology, personalized cell therapies, iPSC-derived treatments, regenerative medicine, chronic degenerative diseases, automated biomanufacturing, healthspan enhancement, vision loss therapy, Parkinson's disease therapy, cell replacement therapies, tissue engineering, organ replacement therapies, stem cell therapy, machine-enabled medicine, scalable biotech solutions

Services & Products

Personalized regenerative medicine
AI-driven optical bioprocessing
Patient-specific biomanufacturing
Scalable bioprocess solutions

Target Customers

Patients with degenerative diseases Healthcare facilities Biotech and pharmaceutical companies

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $25.00M 1
US Department of Health and Human Services
01 Sep 2024
Series A $80.00M 5
Felicis Ventures 8VC Khosla Ventures
Felicis Ventures, 8VC +3
01 Jan 2022
Seed $16.00M 4
8VC Khosla Ventures The Engine
8VC, Khosla Ventures +2
01 Feb 2021
Seed Undisclosed 1
Khosla Ventures
Khosla Ventures
01 Mar 2019
Grant Undisclosed 1
MassChallenge
MassChallenge
01 Nov 2017
Spinout $10.00K 1
Photon Fund
Photon Fund
01 Feb 2017

Latest News

View All
Alumni startup secures 16M in funding — Seas.harvard.edu
Alumni startup secures 16M in funding
Seas.harvard.edu Feb 03, 2021

FAQ About Cellino

Awaken your best stem cells—through machines.
Cellino was founded in 2017.
Cellino is headquartered in Cambridge, United States.
Cellino operates in Biotechnology and Design. Its work centres on biomanufacturing technology, personalized cell therapies, iPSC-derived treatments and regenerative medicine. Its customers include Patients with degenerative diseases, Healthcare facilities and Biotech and pharmaceutical companies.
Cellino has a B2B, D2C and B2D business model. Its revenue comes from Service Fee, Licensing and Usage Based.
Cellino has approximately 112 employees.
Cellino has completed 6 funding rounds, raising a total of $121.01M. The latest funding stage is Series A.
Cellino offers: Personalized regenerative medicine, AI-driven optical bioprocessing, Patient-specific biomanufacturing, Scalable bioprocess solutions.

Source: BounceWatch company record for Cellino, https://bouncewatch.com/company/cellino, updated 5 November 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout